Cote John D.

Director Cote buys 5,800 GPGI shares at $17.10; stock down 29.9% from 52-week high, company unprofitable with -$174.7M net income.

John D. Cote, a director at GPGI, purchased 5,800 shares at $17.10 on 2026-03-17, representing his first open-market position in the stock. The purchase occurs within a cluster of 2 other insider buys in the past 14 days, suggesting coordinated board-level activity. However, context severely constrains bullish interpretation: GPGI is deeply unprofitable (net income of $-174,696,000.00 in its most recent full fiscal year), revenue contracted 85.8% year-over-year, and the stock has fallen 28.0% in 30 days and 29.9% from its 52-week high of $25.32. Additionally, Cote's cross-ticker track record shows 7 prior open-market buys with a 90-day win rate of 0.00% and an average 90-day return of -21.0%, indicating no demonstrated accuracy in timing stock purchases across his transaction history. The cluster buy alone does not offset the deteriorating fundamentals and the director's poor historical returns on similar trades.

Director Cote John D. buys 552 shares at blended average $142.29 (3 transactions) at RHLD; stock down 17.2% in 30 days, down 26.0% in 90 days.

Director John D. Cote purchased 552 shares across 3 separate transactions on 2026-03-17, accumulating his first position in RHLD for $78,544.76 at a blended average price of $142.29. The purchase occurred while RHLD stock has declined 17.2% over the prior 30 days and 26.0% over the prior 90 days, trading 31.8% below its 52-week high of $226.37. Cote's cross-ticker track record shows 5 prior buys with an average 90-day return of -21.0% and a 0.00% win rate, indicating his recent purchase activity has coincided with periods of subsequent losses. The company's recent fundamentals remain challenged, with net income of $-231.0K over the latest quarter despite 9.9% annual revenue growth, underscoring continued operational strain.

Director Cote buys 233,070 shares of CMPO at $16.57 for $3.9M, expanding stake 36.0%; cluster of 2 other insiders buying within 14 days.

John D. Cote, a director, purchased 233,070 shares at $16.57 on 2025-02-20, totaling $3,861,969.90 and increasing his holdings to 879,963 shares from 646,893 shares (+36.0%). This purchase occurs as part of a cluster pattern with 2 other insiders also buying within the past 14 days—including Cote's own buys on 2025-02-14, 2025-02-13, and 2025-02-12, demonstrating concentrated accumulation activity over a narrow time window. The company shows mixed fundamentals: positive annual revenue growth of +3.2% to $107,135,000, but significant recent losses of -$42,060,000 in net income and a P/E of 15.64. The current price of $16.11 sits 6.3% below the 52-week high of $17.20, placing the transaction near recent highs rather than at depressed levels. The clustering of multiple insider buys warrants attention to whether these are scheduled trades or driven by independent conviction about near-term prospects.

Director John D. Cote purchased 646,893 shares across 3 trades (Feb 12-14) for $9,986,149.96; cluster pattern with 2 other insiders buying within 14 days.

John D. Cote, a CompoSecure director, executed 3 separate purchases totaling 646,893 shares for $9,986,149.96 over three consecutive trading days (Feb 12-14, 2025) at a blended average price of $15.44. This represents a substantial commitment to the company, with Cote moving from zero holdings to 646,893 shares post-transaction. The purchases occur within a cluster pattern: 2 other insiders also bought within the past 14 days. Context matters: CompoSecure is currently trading at $15.64, near the 52-week high of $16.55 and up 13.2% over the past 90 days, but the company is unprofitable with a net loss of $42,060,000.00 against $107,135,000.00 in quarterly revenue. The multi-insider buying pattern during a near-52-week-high price period, combined with ongoing operational losses, warrants investor attention to understand management's underlying rationale and expectations.